Illumina, Inc. announced significant changes to its Board of Directors on March 25, 2025. Scott Gottlieb, MD, who has served on the Board since 2020, was elected non-executive Chair. Additionally, Keith Meister, founder, Managing Partner, and Chief Investment Officer of Corvex Management, is set to join the Board of Directors on March 28, 2025.
Stephen MacMillan, who joined the Illumina Board in June 2023, will retire from the board in preparation for the company's upcoming annual meeting of shareholders. Mr. Meister's appointment is notable as his hedge fund, Corvex Management, holds a 2.5% stake in Illumina, and he brings a strong record of supporting value creation for shareholders.
Dr. Gottlieb expressed honor in his new role, emphasizing Illumina's groundbreaking innovations and commitment to profitable growth. Mr. Meister stated his confidence in Illumina's strategy to expand its role in genomics and accelerate revenue growth, indicating a collaborative effort to enhance shareholder value.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.